Navigation Links
ValGenesis, Inc. Achieves SSAE 16 SOC 2 Type 1 Audit Certification
Date:8/22/2013

FREMONT, Calif., Aug. 22, 2013 /PRNewswire/ -- ValGenesis Inc., the market leader in enterprise Validation Management Software solutions, today announced that the company has successfully completed a Service Organization Control 2 (SOC 2) Type 1 certification under AT Section 101.  Completion of the SOC 2 Type I certification indicates that processes, procedures and controls adopted by ValGenesis Inc. in their validated private cloud have been formally evaluated and tested by an independent accounting and auditing firm.  The certification included the company's controls related to the Trust Services Principles and Criteria of Security and Availability.

Hosted ValGenesis Validation Lifecycle Management System (VLMS), through its validated private cloud, allows companies of any size to manage their Validation Lifecycle, Risk and Change management processes, as a 100% paperless process, with built-in best practices. Organizations with certification and compliance requirements such as FDA, EMA and HIPAA etc. may request and leverage the ValGenesis SOC 2 Type I report as part of their compliance strategy.

"SOC 2 exams are rigorous independent assessments, geared toward technology service providers, especially providers of hosting solutions to regulated manufacturing companies," said Siva Samy, Chief Product Strategist, ValGenesis, Inc. "With our successful completion of certification, we are able to provide our customers with greater insights into our controls, procedures and systems for our hosting solution."

This certification is also an important step for any Software-as-a-Service (SaaS) provider that supports outsourced, mission-critical, and information technology services. The audit includes a full assessment of:

  • Security: Data centers are protected against unauthorized access (both physical and logical).
  • Availability: Data centers are available for operation and use as committed or agreed.

A SOC 2 examination is widely recognized, because it represents that a service organization has been through an evaluation of their control activities as they relate to the applicable Trust Services Principles and Criteria.

About ValGenesis

ValGenesis, Inc. is the leading provider of an innovative software platform designed to provide the foundation for compliance-based validation activities in Life Sciences companies. ValGenesis provides the first Enterprise application to manage the corporate validation lifecycle process. Through an industry peer review committee, the Parenteral Drug Association (PDA) recognized the ValGenesis solution with its very prestigious New Innovative Technology award. The ValGenesis Suite is designed to be fully compliant with FDA 21 CFR Part 11 requirements. For more information, visit the ValGenesis website at http://www.valgenesis.com.

Media Contact:

Mike Beaudro
Marketing Manager
ValGenesis, Inc
47102 Mission Falls Court
Fremont, CA 94539
Ph: 510 445 0505

Read more news from ValGenesis Inc.


'/>"/>
SOURCE ValGenesis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
2. Heptares Achieves First Research Milestone in Research Collaboration with Cubist
3. MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy
4. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
5. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
6. Relievant Medsystems Achieves Completion of Interim Safety Data Analysis of Intracept in SMART Pivotal Study and Expands Senior Leadership Team
7. Armada Health Care Achieves Full URAC Accreditation
8. Instrumentation Laboratory Achieves Record Sales In 2012
9. Echo Therapeutics Achieves ISO 13485 Certification
10. First Product in Tris Pharmas Collaboration with Vernalis Achieves Proof-of-Concept, Triggering Milestone Payment to Tris
11. Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration with Ono Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... Mass., May 10, 2017 Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended April 1, ... of $1.84 increased 666.7% compared to the prior year ... resulted in a significant gain, while non-GAAP diluted EPS ... 3.2%, or 3.8% in constant currency terms.  Excluding the ...
(Date:5/10/2017)... Radiology has become the number one diagnostic ... spiraled to the number one ranking as a result.  ... before as the most complete and reliable method for ... back pain an MRI may confirm a suspected herniated ... in entirely different treatment protocols.  In these circumstances, patients ...
(Date:5/9/2017)...  Demonstrating its commitment to representing research- based ... Pharmaceutical Research and Manufacturers of America (PhRMA) today ... now have to meet new research and development ... join PhRMA. "By putting in place ... clear message that being a member of PhRMA ...
Breaking Medicine Technology:
(Date:5/24/2017)... IL (PRWEB) , ... May 24, 2017 , ... ... the most prominent for-profit and nonprofit hospitals and health systems in the nation ... turned around their institutions, led professional organizations and been instrumental in developing successful ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... Population Health and Clinical Integration company, announced today that its iClinic V12.2 solution ... (PCMH) 2017 Prevalidation. NCQA recently introduced PCMH 2017 standards which emphasize team-based ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... have remained steady since 2009, according to a Workers Compensation Research Institute (WCRI) ... Monitoring the North Carolina System: CompScope™ Benchmarks, 17th Edition looks at ...
(Date:5/23/2017)... ... , ... London, May 23, 2017: Walter Schindler, the Founder and Managing Partner ... Speaker and Contributor to a weeklong series of classes, meetings, field trips and special ... Walter Schindler and SAIL Capital have received an increasing number of ...
(Date:5/23/2017)... ... May 23, 2017 , ... MedTech For Solutions has announced ... laboratory, to provide hands-on training utilizing cutting-edge equipment at its recently-opened OvaTools Andrology ... MedTech Group Purchasing vendor , will provide specialized equipment to ensure OvaTools participants ...
Breaking Medicine News(10 mins):